| First Author | Oz HS | Year | 2005 |
| Journal | Med Sci Monit | Volume | 11 |
| Issue | 3 | Pages | BR69-73 |
| PubMed ID | 15735556 | Mgi Jnum | J:127866 |
| Mgi Id | MGI:3765162 | Citation | Oz HS, et al. (2005) Metallothionein overexpression does not protect against inflammatory bowel disease in a murine colitis model. Med Sci Monit 11(3):BR69-73 |
| abstractText | BACKGROUND: We evaluated whether modulation of metallothionein (MT, and subsequent oxidative stress) would influence the development and progression of colitis. MATERIAL/METHODS: MT-transgenic (MT-TG), MT-knockout (MT-KO), and wild-type (WT) mice were treated with Dextran Sodium Sulfate (DSS) to induce colitis compared to controls (no DSS). RESULTS: The DSS treated MT-TG and MT-KO mice responded in a manner similar to that of DSS treated WT mice, with all groups developing severe colitis. The colonic MT content in DSS treated animals increased drastically when compared to controls. The colonic and blood levels of the antioxidant, glutathione (GSH), were significantly reduced in DSS treated MT-TG and MT-KO mice. Howevei there was no significant difference in the cysteine levels in these mice. The subeellular level of MT was highest in intestinal crypts loci of MT-TG mice and was not observed in MT-KO mice as well as in the inflammatory lesions. CONCLUSIONS: We conclude that MT does not appear to influence the development or progression of intestinal pathology in the DSS animal model of IBD. |
